This HTML5 document contains 191 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1245/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10https://scigraph.springernature.com/pub.10.1245/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q47888135
rdf:type
wikibase:Item
schema:description
2013年学术文章 artigo científico научная статья наукова стаття, опублікована в серпні 2013 artículu científicu article scientific 2013年學術文章 2013年学术文章 artikull shkencor מאמר מדעי научни чланак vědecký článek article scientifique bài báo khoa học wissenschaftlicher Artikel vedecký článok 2013年學術文章 мақолаи илмӣ আগস্ট ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2013年学术文章 scientific article published in August 2013 artigo científico scientific article published in August 2013 научна статия bilimsel makale vitenskapelig artikkel 2013年學術文章 2013年学术文章 naučni članak artykuł naukowy article científic artigo científico научни чланак 2013年学术文章 2013年の論文 vitskapeleg artikkel tudományos cikk 2013년 논문 2013年學術文章 articol științific artikulong pang-agham scienca artikolo videnskabelig artikel บทความทางวิทยาศาสตร์ 2013年学术文章 scientific article published in August 2013 vetenskaplig artikel articolo scientifico επιστημονικό άρθρο 2013年學術文章 tieteellinen artikkeli 2013 nî lūn-bûn artikel ilmiah artículo científico publicado en 2013 teaduslik artikkel wetenschappelijk artikel სამეცნიერო სტატია مقالة علمية نشرت في أغسطس 2013
p:P577
wds:Q47888135-B06CBD41-E3B7-4BB5-90F9-D5FCAB5D55C8
wdt:P577
2013-08-01T00:00:00Z
p:P2888
wds:Q47888135-33C9096F-2103-4285-9D04-86075FF9E707
wdt:P2888
n10:s10434-013-3161-9
p:P2860
wds:Q47888135-E339CB6C-7DC8-4F06-B8F3-EDA8EE0CD376 wds:Q47888135-E8A7CFA6-BCE8-4894-8C67-023E98020609 wds:Q47888135-D6303982-48BA-44FC-BCAC-A6028C90E45C wds:Q47888135-DE07D9F9-904E-4892-B5A8-32E44593DE33 wds:Q47888135-DF5113A3-235C-458F-9539-743B5DBBD848 wds:Q47888135-E0DC6301-80DD-4DF1-A02E-21719680F8E1 wds:Q47888135-B9CC8749-5909-462A-A14A-A82B495DC123 wds:Q47888135-C5C266A3-3187-4772-AE66-42AEB864700A wds:Q47888135-D3E0C138-F397-41BF-A566-9DC92FA15126 wds:Q47888135-B5982089-3FC2-48F3-9635-25261CC4A199 wds:Q47888135-9CBF4FB3-7EB6-4E8F-B930-F5DD6E4E3944 wds:Q47888135-9DAA77BB-EC2C-4F5D-9DCC-A3C6A1810C47 wds:Q47888135-00CEA47A-3533-42C3-884F-B13868B27C0E wds:Q47888135-0357B8F9-1303-42EB-A70F-FF2395DEE5C1 wds:Q47888135-00640B31-49E4-4A27-A8B9-9A8D4ACEC6F7 wds:Q47888135-910F3D0C-CC77-4DA5-9CB8-E8FE33251234 wds:Q47888135-93D0D34B-0F6D-40DD-A6F5-A927162691D8 wds:Q47888135-96E22B93-3C58-4B94-87B5-DB9625BE3CA0 wds:Q47888135-74FBD312-B68D-424F-A51D-6D898B1EBB2E wds:Q47888135-7C96D578-259C-44B4-A2DE-6E3E0463D364 wds:Q47888135-8BBF83B6-C21E-41E5-86CD-3873AA5F927E wds:Q47888135-630BFCAB-5989-4771-B619-20039970C52D wds:Q47888135-6CAAFC84-6301-4322-9AD5-ED44E16F5F5A wds:Q47888135-5A8653CA-398F-48D3-90EE-CEF257424F10 wds:Q47888135-5ADECC48-31F2-436C-8838-5CEC1AB65967 wds:Q47888135-5CB0E1D4-FD33-4D37-8010-D3EC06ECBF90 wds:Q47888135-5FF0FD45-4ECF-4DDA-9AEC-AF1B3BBF99FF wds:Q47888135-414D3FC8-6B78-4472-A628-F049B284FCCA wds:Q47888135-22D3CC87-71F7-4183-BE6D-B0889FFA0DAA wds:Q47888135-29C91584-6959-47B3-806B-71773F4B5F53 wds:Q47888135-2F8C8632-FD05-434C-A523-AA2E02366521 wds:Q47888135-1574602F-B1C8-4885-98BB-DC7844F24EBD wds:Q47888135-1A0B497D-4767-4C3D-A2DA-A553E601404D wds:Q47888135-1A3EAEF8-E137-4719-967D-4045683D497E
wdt:P2860
wd:Q34546440 wd:Q29616287 wd:Q34049260 wd:Q34602771 wd:Q37809674 wd:Q36476666 wd:Q30452636 wd:Q46966648 wd:Q43547525 wd:Q34190493 wd:Q36871043 wd:Q42688324 wd:Q32135051 wd:Q42662128 wd:Q27860681 wd:Q43845068 wd:Q37460990 wd:Q29620559 wd:Q29547558 wd:Q33995820 wd:Q40829631 wd:Q46473461 wd:Q36549218 wd:Q40357466 wd:Q46781781 wd:Q37938812 wd:Q37939892 wd:Q57847000 wd:Q27860574 wd:Q44978576 wd:Q33756489 wd:Q35787410 wd:Q34371493 wd:Q27860525
p:P2093
wds:Q47888135-337E2627-97CA-4E2C-B6F6-20D165244A5E wds:Q47888135-554DAF1E-D361-443D-8D82-08DA49542B8E wds:Q47888135-440925D9-5CB8-4F29-99E3-0A3D50846127 wds:Q47888135-8C3E4422-A2E4-4B98-B29B-BD0358DA80E6 wds:Q47888135-AADB5AF0-A8F1-4FA4-9ABF-7F26BE5A1A49 wds:Q47888135-B77C01FB-E2A4-4478-83AE-6FD80086F4D1 wds:Q47888135-B7DADBA9-A786-44E8-BFCA-048752B5CD97 wds:Q47888135-B7115D4C-165A-4F46-8CF8-8FDE4C4D8ECD wds:Q47888135-E916B9B8-0B7F-4F13-BDAB-7E5E6230F8E8 wds:Q47888135-ED2A7FAD-8A30-4415-9691-AC065C3BAB22
wdt:P2093
Barry C Lembersky Ramesh K Ramanathan Alyssa M Krasinskas A James Moser Gerard J Abood George Van Buren Ryan P Smith Douglas M Potter Nathan Bahary Yongli Shuai
rdfs:label
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma.
skos:prefLabel
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma.
schema:name
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma.
p:P50
wds:Q47888135-05C86162-45BE-4CE9-84BA-612BCDA8A6D0 wds:Q47888135-33B87F4F-A704-4CEF-B806-B09CF9494FDD wds:Q47888135-6D5B9F8F-CFEC-4BD7-BD4C-D6B1D40173E8
wdt:P50
wd:Q92244196 wd:Q95836389 wd:Q97424233
p:P1476
wds:Q47888135-E53C7AE8-5143-463D-BAEC-52702F06C68B
wdt:P1476
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma.
p:P304
wds:Q47888135-FDAD4569-33AF-4DDF-A2C3-596A3ACD132D
wdt:P304
3787-3793
p:P31
wds:Q47888135-045E8E16-DD58-4674-938E-6E05624296CC
wdt:P31
wd:Q13442814
p:P921
wds:Q47888135-8E1A504A-7971-407E-A96F-FB83BD8F8DC0 wds:Q47888135-E2563CBF-856B-4E6A-92B6-ADF47C5EB4CE wds:Q47888135-F5FA59BB-29BE-4271-B71B-6534905AB859
wdt:P921
wd:Q413299 wd:Q180507 wd:Q356033
p:P698
wds:Q47888135-1F9EC2B9-A54A-4AAF-B8D5-5B99E3A61955
wdtn:P698
n12:23904005
wdt:P698
23904005
p:P1433
wds:Q47888135-D100D401-D839-467B-92CA-0B004FD7E367
wdt:P1433
wd:Q2853069
p:P433
wds:Q47888135-FCDD21AB-E6DF-4312-8B94-5C65750DD09D
p:P478
wds:Q47888135-4B24D692-4F15-4710-B390-675269AAD406
wdt:P433
12
wdt:P478
20
p:P356
wds:Q47888135-69A32787-77E9-444D-B48A-B96E443D00D1
wdtn:P356
n8:S10434-013-3161-9
wdt:P356
10.1245/S10434-013-3161-9
p:P5875
wds:Q47888135-241CA339-C3C7-4074-9CB1-FDCE8FEDF85B
wdt:P5875
254261454
p:P6179
wds:Q47888135-3CE018FC-C53C-4E46-AB03-ABEA53F1D441
wdt:P6179
1021249329